Can Oral Prednisone Help Trochanteric Bursitis?
Yes, oral prednisone can be used to treat trochanteric (hip) bursitis that has not responded to NSAIDs, though local corticosteroid injection is the preferred route of administration for this condition.
Treatment Approach for NSAID-Refractory Trochanteric Bursitis
First-Line After NSAID Failure: Local Corticosteroid Injection
When NSAIDs fail to control trochanteric bursitis pain, local corticosteroid injection directly into the trochanteric bursa is the standard next step 1. The ACR guidelines specifically mention that trochanteric pain may be relieved by trochanteric injection, and these injections should be guided by imaging 1.
A 2018 randomized trial demonstrated that corticosteroid injection (80 mg methylprednisolone) provided significant pain relief at both 2 weeks and 6 months 2. The study showed pain scores improved from baseline to 3.9 ± 2.0 cm at 6 months, with therapeutic duration averaging 4.7 months 2. Importantly, anatomic landmark-guided injection was equally effective as ultrasound-guided injection and more cost-effective 2.
Role of Oral Prednisone
While local injection is preferred, oral prednisone can be effective for bursitis when systemic corticosteroid therapy is warranted. A 1993 case report demonstrated complete resolution of iliopsoas bursitis (a related hip bursa condition) with 25 mg/day oral prednisone over one month, with both the palpable mass and pain disappearing 3.
The typical oral prednisone dosing for inflammatory conditions ranges from 5-60 mg daily, depending on severity 4. For trochanteric bursitis specifically, a reasonable approach would be:
- 10-20 mg daily for 7-14 days, then taper
- Take in the morning (before 9 AM) to minimize HPA axis suppression 4
- Take with food to reduce gastric irritation 4
Important Caveats and Considerations
Oral corticosteroids carry more systemic side effects than local injection 4. The FDA label warns about:
- HPA axis suppression with prolonged use
- Increased infection risk (including reactivation of latent TB, strongyloides, hepatitis B)
- Metabolic effects (hyperglycemia, hypertension, fluid retention)
- Osteoporosis risk (use calcium and vitamin D supplementation) 4
The evidence for oral corticosteroids in tendinopathies is mixed. A 2005 guideline notes that while corticosteroids may provide acute pain relief, they don't alter long-term outcomes and may have deleterious effects on tendon tissue 5. However, bursitis is distinct from tendinopathy—it's an inflammatory condition of the bursa rather than degenerative tendon disease, making corticosteroids more mechanistically appropriate.
Clinical Algorithm
If local injection is feasible: Proceed with trochanteric bursa injection (80 mg methylprednisolone with lidocaine) using anatomic landmarks with at least a 2-inch needle 2
If local injection has failed or is not feasible (patient refusal, anticoagulation concerns, anatomic difficulty):
- Start oral prednisone 10-20 mg daily for 7-14 days
- Taper over 1 week after symptoms improve
- Add calcium/vitamin D supplementation
- Monitor for infection, hyperglycemia
If oral prednisone fails: Consider alternative diagnoses (referred pain from lumbar spine, gluteal tendinopathy, hip joint pathology) and obtain MRI 1
Common Pitfalls
- Using insufficient needle length for injection: At least a 2-inch (50.8 mm) needle is required to consistently reach the trochanteric bursa 2
- Prolonged oral corticosteroid use: Avoid courses longer than 2-3 weeks to minimize systemic side effects
- Abrupt discontinuation: Taper gradually after courses longer than 1-2 weeks to prevent adrenal insufficiency 4
- Missing alternative diagnoses: Lumbar spinal stenosis is significantly associated with trochanteric pain and should be evaluated 6
Bottom line: While oral prednisone can work for trochanteric bursitis, local injection remains superior due to targeted delivery with fewer systemic effects. Reserve oral prednisone for situations where injection is not possible or has failed.